This inventor holds 1 USPTO granted patent. Top assignees: Kowa Company Limited, Nissan Chemical Industries Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2008
Title: Takashi Maejima: Innovator in Hyperlipidemia Treatment
Introduction
Takashi Maejima is a notable inventor based in Higashimurayama, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of hyperlipidemia. His innovative approach has led to the development of a unique method that combines specific medications to effectively manage cholesterol levels.
Latest Patents
Takashi Maejima holds a patent for a method for treating hyperlipidemia. This patent outlines a process that involves administering effective doses of ezetimibe and pitavastatin or a salt or lactone derivative thereof. This innovative method aims to provide a more effective treatment option for individuals suffering from hyperlipidemia or hypercholesterolemia.
Career Highlights
Throughout his career, Takashi Maejima has worked with prominent companies such as Kowa Company Limited and Nissan Chemical Industries Limited. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical treatments.
Collaborations
Takashi has collaborated with notable professionals in his field, including Taro Aoki and Hiroyuki Yamazaki. These collaborations have fostered a productive environment for innovation and have led to significant advancements in medical treatments.
Conclusion
In summary, Takashi Maejima is a distinguished inventor whose work in treating hyperlipidemia has made a meaningful impact in the medical field. His innovative methods and collaborations with industry leaders highlight his commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile